Is there a case for the early use of bisphosphonates in smouldering myeloma and MGUS? (Bisphosphonates in SMM & MGUS).
Sanders
J
J
Crawford
B
B
Gibson
J
J
Joy Ho
P
P
Iland
H
H
Joshua
D
D
D000368:Aged; D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D010024:Osteoporosis / Q000188:drug therapy* / Q000209:etiology; D010265:Paraproteinemias / Q000150:complications* / Q000188:drug therapy; D000077211:Zoledronic Acid